And so I don't know they're going to get any more to do the trials, which are as very expensive to run
De Souza RL, Matsuura M, Eckstein F, Rawlinson SC, Lanyon LE, Pitsillides AA
Understanding Self-Pay Pricing for GLP-1 Medications Not every insurance plan covers GLP-1s for weight loss, and some patients prefer to stay outside of insurance altogether
Truveta Data enables a comprehensive view of how these therapies are being adopted across populations and care settings, providing timely insight into how changes in guidance, demand, and access are shaping treatment in practice
Reactive oxygen species mediate oridonin-induced apoptosis through DNA damage response and activation of JNK pathway in diffuse large B cell lymphoma
Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)-a multicentre, double-blind, randomised, placebo-controlled trial